Business Context and Reporting Period
Company: Evogene Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: May 20, 2026
Reporting Period: First Quarter ended March 31, 2026
Evogene Ltd. filed this Form 6-K to announce its financial results for the first quarter of 2026. The filing incorporates by reference a press release (Exhibit 99.1) and a slide presentation (Exhibit 99.2) used during a conference call held on May 20, 2026.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. The following metrics are referenced as being available in the attached exhibits but are not explicitly stated in this text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Investors must refer to Exhibit 99.1 (Press Release) for GAAP financial statement tables.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Such analysis is contained within the incorporated press release and slide presentation.
Guidance, Outlook, and Risks
Management Commentary: Management held a conference call on May 20, 2026, to discuss the quarterly results and business outlook. Details of this commentary are found in the attached slide presentation (Exhibit 99.2).
Guidance and Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed in the cover text of this Form 6-K.
Key Facts for Investor Verification
- Verify the specific revenue and net loss figures in the attached Press Release (Exhibit 99.1).
- Review the slide presentation (Exhibit 99.2) for management's updated business outlook and strategic initiatives.
- Confirm the impact of the Q1 2026 results on the company's cash position and runway, as these figures are not in the cover text.
- Note that the GAAP financial tables in the press release are incorporated into the company's active registration statements (Form F-3 and Form S-8).